NIH-funded research R01 grant

Targeting fatty acid metabolism to treat colon cancer

Official title: Fatty Acid Synthase as a Novel Molecular Target for Colon Cancer Treatment

Funded at University of Kentucky · NIH-11039999 · Data updated 2026-11-12

This study is looking at how fat processing in the body affects colon cancer and is testing new medications that target a specific enzyme to help improve treatment for people with colorectal cancer.

More Colon Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startMarch 1, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$402,968
NIH project number5R01CA284532-02
Project IDNIH-11039999 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with resectable colon cancer who are seeking new treatment options.

Less likely to help

Patients with advanced or metastatic colon cancer who are not eligible for surgical intervention may not benefit from this research.

What this research studies

This research investigates the role of fatty acid metabolism in colon cancer and how it contributes to tumor growth and treatment resistance. The study focuses on a key enzyme, fatty acid synthase (FASN), which is crucial for cancer cell survival and proliferation. Researchers are developing and testing new small molecule inhibitors that specifically target FASN, aiming to improve treatment outcomes for patients with colorectal cancer. The approach includes clinical trials to evaluate the safety and effectiveness of these inhibitors in patients with resectable colon cancer.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for colon cancer, potentially improving survival rates and quality of life for patients.

How similar studies have gone: Previous research has shown promising results in targeting fatty acid metabolism in cancer treatment, indicating potential for success with this novel approach.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Gao, Tianyan — University of Kentucky
  • Study coordinator: Gao, Tianyan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.